AIM IMMUNOTECH INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+51.0% +$2M
$-2M
Free Cash Flow↑+51.0% +$2M
$-2M
Investing Cash Flow↓-11.4% -$38K
$296K
Financing Cash Flow↑+162.2% +$2M
$3M
Capex
$0
Stock-Based Comp↓-100.0% -$196K
$0
Debt Repaid
$660K
D&A↑+0.0% +$0
$9K
SBC Allocated Expense↓-100.0% -$196K
$0
SBC Unrecognized Cost
$214K